Abstract
Disease surveillance is an integral component of government policy, allowing public health professionals to monitor transmission of infectious diseases and appropriately apply interventions. To aid with surveillance efforts, there has been extensive development of mathematical models to help inform policy decisions, However, these mathematical models rely upon data streams that are expensive and often only practical for high income countries. With a growing focus on equitable public health tools there is a dire need for development of mathematical models that are equipped to handle the data stream challenges prevalent in low and middle income countries, where data is often incomplete and subject to aggregation. To address this need, we develop a mathematical model for the joint estimation of the effective reproduction number and daily incidence of an infectious disease using incomplete and aggregated data. Our investigation demonstrates that this novel mathematical model is robust across a variety of reduced data streams, making it suitable for application in diverse regions.
Author summary Monitoring the transmission of infectious diseases is an important part of government policy that is often hindered by limitations in data streams. This is especially true in low and middle income countries where health sectors have less funding. In this work we develop a mathematical model to enhance disease surveillance by overcoming these data limitations, providing accurate inferences of relevant epidemiological parameters.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available human data that were originally located at https://discover.data.vic.gov.au/dataset/victorian-sars-cov-2-cases-by-age-group.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
